Skip to main content
TipRanks
Go Ultimate75% OFF

Atlas Trinity Tech (ATTT) Risk Analysis

104 Followers
Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F). Risk factors show the challenges a company faces. Investors can consider the worst-case scenarios before making an investment. TipRanks’ Risk Analysis categorizes risks based on proprietary classification algorithms and machine learning. Atlas Trinity Tech disclosed 65 risk factors in its most recent earnings report. Atlas Trinity Tech reported the most risks in the “Finance & Corporate” category.

Risk Overview Q1, 2026

Source: the company's latest filing for the period ended Mar 31, 2026, filed Jul 31, 2026

Risk Distribution
65Risks
Sector Avg.Finance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Risk Change Over Time

Atlas Trinity Tech disclosed risks per quarterNo. of Risks65Q12026Showing: Q1, 2026
Risks removedRisks addedRisks changedAtlas Trinity Tech Risk Factors
Risk Changed (8)
  • Share Price & Shareholder Rights - Risk 1
    We received a deficiency notice from Nasdaq regarding the minimum bid price requirement, and we may be unable to maintain compliance with Nasdaq continued listing requirements in the future.

    On October 14, 2025, we received a notice from the Nasdaq Listing Qualifications Department that the bid price of our Ordinary Shares had closed below US$1.00 per share for 30 consecutive business days and that we no longer satisfied the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). To regain compliance, we effected a one-for-sixteen share consolidation that became effective on November 7, 2025. Although we regained compliance, there can be no assurance that we will continue to satisfy the minimum bid price requirement or the other continued listing requirements of Nasdaq in the future, and any delisting of our Ordinary Shares would materially and adversely affect their liquidity and market price. In addition, on July 22, 2026, the SEC approved a Nasdaq rule change requiring the immediate suspension and delisting of any listed company whose market value of listed securities ("MVLS") falls below $5 million for 30 consecutive business days, subject to limited review by a Nasdaq Hearings Panel. Under the approved rule, a timely request for a hearing will not stay the suspension of trading, and our securities would generally trade on the over-the-counter market during any appeal process. The Nasdaq Hearings Panel may grant a limited exception period (not to exceed 180 days) to demonstrate compliance with initial listing requirements, but there can be no assurance that such relief would be granted. Our ability to maintain compliance with the $5 million MVLS requirement depends on a number of factors, including the market price of our Ordinary Shares and the number of our issued and outstanding shares. The market price of our Ordinary Shares may be volatile and could decline for reasons beyond our control, including: - general market conditions or downturns in the broader equity markets;- sector-specific or industry-wide volatility;- changes in interest rates or macroeconomic conditions;- geopolitical events;- actual or perceived short selling activity or other trading dynamics;- reduced liquidity or limited public float; and      - investor perceptions regarding our business, prospects, or financial condition. If our MVLS were to fall below $5 million for 30 consecutive business days, Nasdaq would issue a staff delisting determination and immediately suspend trading of our Ordinary Shares on Nasdaq. Any suspension or delisting of our Ordinary Shares from Nasdaq could materially and adversely affect our business, financial condition, results of operations, and the value of our Ordinary Shares. In the event that our Ordinary Shares is delisted from Nasdaq, as a result of our failure to comply with the Minimum Bid Price Requirement, or due to our failure to continue to comply with any other requirement for continued listing on Nasdaq, and is not eligible for listing on another exchange, trading in the shares of our Ordinary Shares could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our Ordinary Shares, and it would likely be more difficult to obtain coverage by securities analysts and the news media, which could cause the price of our Ordinary Shares to decline further. Also, it may be difficult for us to raise additional capital if we are not listed on a national exchange.

  • Share Price & Shareholder Rights - Risk 2
    The share consolidation may not result in a sustained increase in the market price of our Ordinary Shares.

    The one-for-sixteen share consolidation that became effective on November 7, 2025 reduced the number of our outstanding Ordinary Shares and increased the par value from US$0.00000625 to US$0.0001 per share. The market price of our Ordinary Shares following the share consolidation depends on our performance and other factors unrelated to the number of shares outstanding, and the share consolidation may not result in a sustained increase in the market price or improved liquidity of our Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 3
    Future issuances of our Ordinary Shares, including under our shelf registration statement, may cause substantial dilution and adversely affect the market price of our Ordinary Shares.

    In July 2025 we completed a public offering of Ordinary Shares, and in June 2026 we completed a registered direct offering of 3,149,832 Ordinary Shares (on a post-consolidation basis) under our shelf registration statement on Form F-3 (Registration No. 333-290696), which permits us to offer up to US$500,000,000 of securities from time to time. If our existing shareholders sell, or indicate an intent to sell, substantial amounts of our Ordinary Shares in the public market, the trading price of our Ordinary Shares could decline significantly. Similarly, the perception in the public market that our shareholders might sell our Ordinary Shares could also depress the market price of our shares. A decline in the price of our Ordinary Shares might impede our ability to raise capital through the issuance of additional Ordinary Shares or other equity securities. In addition, the issuance and sale by us of additional ordinary shares, or securities convertible into or exercisable for our ordinary shares, or the perception that we will issue such securities, could reduce the trading price for our Ordinary Shares as well as make future sales of equity securities by us less attractive or not feasible. It could also dilute the voting power of our Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 4
    We have engaged in transactions with related parties and have relied on the home country practice exemption from Nasdaq shareholder-approval requirements.

    In our June 2026 registered direct offering, two of the investors, Fortune Genesis Holdings Limited and WK Frater Holdings Limited, are affiliates of certain of our directors and of Mr. Liu Zhiwei, who was our largest shareholder at the time of the offering, and each purchased 999,014 Ordinary Shares on the same terms as the other investors. In connection with that offering, we relied on the home country practice exemption in Nasdaq Listing Rule 5615(a)(3) in lieu of the shareholder approval requirements of Nasdaq Listing Rule 5635. Our reliance on foreign private issuer and home country practice exemptions means our shareholders may not have the same protections afforded to shareholders of companies subject to all Nasdaq corporate governance requirements, and our related-party transactions may present conflicts of interest.

  • Debt & Financing - Risk 5
    A substantial portion of our accounts receivable arose near the end of fiscal 2026 from our newly launched service businesses, and our operating cash flow for fiscal 2026 was negative; if we are unable to collect these receivables in a timely manner or to obtain external financing on acceptable terms, our liquidity and financial condition would be materially and adversely affected.

    Our service businesses, conducted through Raytech Innovation and Worry free, commenced or were acquired during fiscal 2026 and expanded significantly toward the end of the year. As a result, our total accounts receivable increased to HKD67,775,993 (US$8,644,897) as of March 31, 2026 from HKD8,144,307 as of March 31, 2025, and we recorded net cash used in operating activities of HKD14,511,287 ( US$1,850,928) for the year ended March 31, 2026. We have to date relied in part on external financing to fund our working capital, including our June 2026 registered direct offering under our Form F-3 shelf registration statement, which raised net proceeds of approximately US$6.08 million. If our service customers fail to settle their balances within the agreed credit periods, if we are required to record allowances for credit losses, or if additional financing is not available on acceptable terms or at all, our liquidity, financial condition and results of operations could be materially and adversely affected, and our shareholders could experience dilution from future equity financings.

  • Corporate Activity and Growth - Risk 6
    Our expansion into personal health care electronics may require significant investment, and we may not realize an adequate return on such investment.

    The development of personal health care electronic products and related services may require significant expenditures, including costs associated with research and development, product design, regulatory compliance, testing, marketing, and working capital. We may need to devote substantial management time and financial resources to this business line. If anticipated demand does not materialize, or if we fail to achieve expected pricing or market acceptance, we may not recover our investments, which could materially and adversely affect our operating results and liquidity.

  • Corporate Activity and Growth - Risk 7
    We may not realize the anticipated benefits of our acquisition of Worry free Group (Hong Kong) Limited, which also exposes us to integration and financial risks.

    On December 23, 2025, our subsidiary Raytech Innovation Limited agreed to acquire 100% of the issued share capital of Worry free Group (Hong Kong) Limited for an aggregate consideration of US$6,099,000, comprising US$4,099,000 in cash and a US$2,000,000 promissory note bearing interest at 2% per annum and maturing on the second anniversary of its issuance. We may fail to integrate the acquired business successfully, to realize the anticipated benefits, or to identify liabilities accurately, and the acquisition has given rise to goodwill that may become impaired. Servicing the promissory note will also require cash resources. Any of these factors could materially and adversely affect our business, financial condition and results of operations.

Read and Evaluate the RiskReserved for Ultimate MembersUpgrade

Risk Highlights Q1, 2026

Main Risk Category
Finance & Corporate
With 30 Risks
Number of Disclosed Risks
65
S&P 500 Average: 32
Recent Changes
10Risks added
1Risks removed
8Risks changed
Since Mar 2026
Number of Risk Changed
8
S&P 500 Average: 1

Risk Word Cloud

we cannot assure that our products can meet consumer preferences and needs, and will continue to gain market acceptance and secure market share.continue to gain market acceptancetwo of our largest shareholders may continue to exert substantial influence over the company following the offering, and their interests may not be aligned with those of our other shareholders.continue to exert substantial influenceraytech holding's lack of effective internal controls over financial reporting may affect its ability to accurately report its financial results or prevent fraud, which may affect the market for and price of raytech holding's ordinary shares.lack of effective internal controlspersonal health care electronic products may not perform as expected for all users, which could result in customer dissatisfaction, reputational harm, or liability exposure.personal health care electronic productsthe enactment of law of the prc on safeguarding national security in the hong kong special administrative region (the "hong kong national security law") could impact our hong kong subsidiaries.hong kong special administrative regionour expansion into the personal health care electronics sector is relatively new, and we may not successfully develop or commercialize products or services in this area.personal health care electronics sectora substantial portion of our accounts receivable arose near the end of fiscal 2026 from our newly launched service businesses, and our operating cash flow for fiscal 2026 was negative; if we are unable to collect these receivables in a timely manner or to obtain external financing on acceptable terms, our liquidity and financial condition would be materially and adversely affected.our newly launched service businessesif we fail to prevent security breaches, improper access to or disclosure of our data or user data, or other hacking and attacks, we may lose users, and our business, reputation, financial condition and results of operations may be materially and adversely affected.fail to prevent security breacheswe may not be able to continue to grow at our historical rate of growth, and if we fail to manage our growth effectively, our business may be materially and adversely affected.our historical rate of growthyou may incur additional costs and procedural obstacles in effecting service of legal process, enforcing foreign judgments or bringing actions in hong kong against raytech holding or its management named in the annual report based on hong kong laws.effecting service of legal process

Risk Factors Full Breakdown - Total Risks 65

Share Price & Shareholder Rights19 | 29.2%
  • Share Price & Shareholder Rights - Risk 1Added
    We received a deficiency notice from Nasdaq regarding the minimum bid price requirement, and we may be unable to maintain compliance with Nasdaq continued listing requirements in the future.

    On October 14, 2025, we received a notice from the Nasdaq Listing Qualifications Department that the bid price of our Ordinary Shares had closed below US$1.00 per share for 30 consecutive business days and that we no longer satisfied the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). To regain compliance, we effected a one-for-sixteen share consolidation that became effective on November 7, 2025. Although we regained compliance, there can be no assurance that we will continue to satisfy the minimum bid price requirement or the other continued listing requirements of Nasdaq in the future, and any delisting of our Ordinary Shares would materially and adversely affect their liquidity and market price. In addition, on July 22, 2026, the SEC approved a Nasdaq rule change requiring the immediate suspension and delisting of any listed company whose market value of listed securities ("MVLS") falls below $5 million for 30 consecutive business days, subject to limited review by a Nasdaq Hearings Panel. Under the approved rule, a timely request for a hearing will not stay the suspension of trading, and our securities would generally trade on the over-the-counter market during any appeal process. The Nasdaq Hearings Panel may grant a limited exception period (not to exceed 180 days) to demonstrate compliance with initial listing requirements, but there can be no assurance that such relief would be granted. Our ability to maintain compliance with the $5 million MVLS requirement depends on a number of factors, including the market price of our Ordinary Shares and the number of our issued and outstanding shares. The market price of our Ordinary Shares may be volatile and could decline for reasons beyond our control, including: - general market conditions or downturns in the broader equity markets;- sector-specific or industry-wide volatility;- changes in interest rates or macroeconomic conditions;- geopolitical events;- actual or perceived short selling activity or other trading dynamics;- reduced liquidity or limited public float; and      - investor perceptions regarding our business, prospects, or financial condition. If our MVLS were to fall below $5 million for 30 consecutive business days, Nasdaq would issue a staff delisting determination and immediately suspend trading of our Ordinary Shares on Nasdaq. Any suspension or delisting of our Ordinary Shares from Nasdaq could materially and adversely affect our business, financial condition, results of operations, and the value of our Ordinary Shares. In the event that our Ordinary Shares is delisted from Nasdaq, as a result of our failure to comply with the Minimum Bid Price Requirement, or due to our failure to continue to comply with any other requirement for continued listing on Nasdaq, and is not eligible for listing on another exchange, trading in the shares of our Ordinary Shares could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our Ordinary Shares, and it would likely be more difficult to obtain coverage by securities analysts and the news media, which could cause the price of our Ordinary Shares to decline further. Also, it may be difficult for us to raise additional capital if we are not listed on a national exchange.

  • Share Price & Shareholder Rights - Risk 2Added
    The share consolidation may not result in a sustained increase in the market price of our Ordinary Shares.

    The one-for-sixteen share consolidation that became effective on November 7, 2025 reduced the number of our outstanding Ordinary Shares and increased the par value from US$0.00000625 to US$0.0001 per share. The market price of our Ordinary Shares following the share consolidation depends on our performance and other factors unrelated to the number of shares outstanding, and the share consolidation may not result in a sustained increase in the market price or improved liquidity of our Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 3Added
    Future issuances of our Ordinary Shares, including under our shelf registration statement, may cause substantial dilution and adversely affect the market price of our Ordinary Shares.

    In July 2025 we completed a public offering of Ordinary Shares, and in June 2026 we completed a registered direct offering of 3,149,832 Ordinary Shares (on a post-consolidation basis) under our shelf registration statement on Form F-3 (Registration No. 333-290696), which permits us to offer up to US$500,000,000 of securities from time to time. If our existing shareholders sell, or indicate an intent to sell, substantial amounts of our Ordinary Shares in the public market, the trading price of our Ordinary Shares could decline significantly. Similarly, the perception in the public market that our shareholders might sell our Ordinary Shares could also depress the market price of our shares. A decline in the price of our Ordinary Shares might impede our ability to raise capital through the issuance of additional Ordinary Shares or other equity securities. In addition, the issuance and sale by us of additional ordinary shares, or securities convertible into or exercisable for our ordinary shares, or the perception that we will issue such securities, could reduce the trading price for our Ordinary Shares as well as make future sales of equity securities by us less attractive or not feasible. It could also dilute the voting power of our Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 4Added
    We have engaged in transactions with related parties and have relied on the home country practice exemption from Nasdaq shareholder-approval requirements.

    In our June 2026 registered direct offering, two of the investors, Fortune Genesis Holdings Limited and WK Frater Holdings Limited, are affiliates of certain of our directors and of Mr. Liu Zhiwei, who was our largest shareholder at the time of the offering, and each purchased 999,014 Ordinary Shares on the same terms as the other investors. In connection with that offering, we relied on the home country practice exemption in Nasdaq Listing Rule 5615(a)(3) in lieu of the shareholder approval requirements of Nasdaq Listing Rule 5635. Our reliance on foreign private issuer and home country practice exemptions means our shareholders may not have the same protections afforded to shareholders of companies subject to all Nasdaq corporate governance requirements, and our related-party transactions may present conflicts of interest.

  • Share Price & Shareholder Rights - Risk 5Changed
    Two of our largest shareholders may continue to exert substantial influence over the Company following the Offering, and their interests may not be aligned with those of our other shareholders.

    Following the closing of the offering of our Ordinary Shares pursuant to our registration statement on Form F-3 (File No. 333-290696), which was declared effective by the Securities and Exchange Commission on December 18, 2025, and the related prospectus supplement dated June 18, 2026, WK Frater Holdings Limited and Fortune Genesis Holdings Limited each beneficially own approximately 17.01% of our outstanding Ordinary Shares. As a result of their significant ownership positions, these shareholders may be able to exert substantial influence over matters requiring shareholder approval, including the election and removal of directors, amendments to our memorandum and articles of association, and the approval of significant corporate transactions such as mergers, business combinations or asset sales. The concentration of ownership in these shareholders may also have the effect of delaying, deterring or preventing a change in control of the Company, and may discourage potential acquirers from making an offer for our securities. In addition, the interests of these shareholders may differ from those of our other shareholders. They may vote their shares in a manner that advances their own interests, which may not be aligned with the interests of the Company or our other shareholders. Any such actions could adversely affect our corporate governance, strategic direction, and the market price of our ordinary shares.

  • Share Price & Shareholder Rights - Risk 6
    Certain of our officers or directors may have actual or potential conflicts of interest because of their equity interests in or positions with Raytech Holdings Company Limited and Zhongshan Raytech.

    Raytech Holding's CEO and director, Mr. Ching, has ownership of Zhongshan Raytech and Raytech Holdings Company Limited, on which we rely for manufacturing collaboration, create, or may create the appearance of, conflicts of interest when these officers or directors are faced with decisions that could have different implications for Zhongshan Raytech and Raytech Holdings Company Limited than for us. These potential conflicts could arise, for example, over matters such as the desirability of changes in our business and operations, funding and capital matters, regulatory matters, and contractual arrangements.

  • Share Price & Shareholder Rights - Risk 7
    If Raytech Holding ceases to qualify as a foreign private issuer, it would be required to comply fully with the reporting requirements of the Exchange Act applicable to U.S. domestic issuers, and it would incur significant additional legal, accounting and other expenses that it would not incur as a foreign private issuer.

    As a foreign private issuer, Raytech Holding is exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements, and Raytech Holding's officers, directors and principal shareholders is exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, Raytech Holding is not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as United States domestic issuers, and it will not be required to disclose in its periodic reports all of the information that United States domestic issuers are required to disclose. However, Raytech Holding may cease to qualify as a foreign private issuer in the future.

  • Share Price & Shareholder Rights - Risk 8
    Raytech Holding is an "emerging growth company" within the meaning of the Securities Act, and if Raytech Holding takes advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make it more difficult to compare Raytech Holding's performance with other public companies.

    Raytech Holding is an "emerging growth company" within the meaning of the Securities Act, as modified by the JOBS Act. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. Raytech Holding has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, Raytech Holding, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of Raytech Holding's financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible, because of the potential differences in accounting standards used. If some investors find Raytech Holding's Ordinary Shares less attractive as a result, there may be a less active trading market for Raytech Holding's Ordinary Shares and Raytech Holding's share price may be more volatile.

  • Share Price & Shareholder Rights - Risk 9
    Our results of operations may be adversely affected by significant share-based compensation expenses, and the issuance of shares under our equity incentive plans will dilute existing shareholders.

    To attract, retain, and motivate highly skilled employees, directors, and consultants, which is critical in a competitive talent market, we utilize share-based awards. Consequently, on September 24, 2024, our Board of Directors adopted, and on October 23, 2024, our shareholders approved, the 2024 Equity Incentive Plan (the "2024 Plan"). The 2024 Plan, which has a ten-year term and authorizes the issuance of up to 2,500,000 of our Ordinary Shares, allows for the grant of various types of equity awards, including Incentive Share Options, Non-statutory Share Options, Restricted Shares, Restricted Share Units, Share Appreciation Rights, Performance Units, and Performance Shares. While these awards are intended to promote our long-term success and align interests with shareholder value, they require us to recognize share-based compensation expenses in our consolidated financial statements. Significant share-based compensation expenses could materially and adversely affect our reported net income (or increase our net loss). Furthermore, any issuance of Ordinary Shares upon the exercise of options or the vesting of other equity awards granted under the 2024 Plan or any future equity incentive plans will result in the dilution of the ownership interests of our existing shareholders, which could also adversely affect the market price of our Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 10
    Although the audit report included in this Annual Report is prepared by U.S. auditors who are subject to PCAOB inspections on a regular basis, there is no guarantee that future audit reports will be prepared by auditors inspected by the PCAOB and, as such, in the future investors may be deprived of the benefits of such inspection. Furthermore, trading in Raytech Holding's securities may be prohibited under the HFCA Act if the SEC subsequently determines Raytech Holding's audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely, and as a result, U.S. national securities exchanges, such as the Nasdaq, may determine to delist Raytech Holding's securities. Furthermore, on June 22, 2021, the U.S. Senate passed the AHFCAA, which would amend the HFCA Act and require the SEC to prohibit an issuer's securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three, thus reducing the time period for triggering the prohibition on trading.

    As an auditor of companies that are registered with the SEC and publicly traded in the United States and a firm registered with the PCAOB, Raytech Holding's auditor is required under the laws of the United States to undergo regular inspections by the PCAOB to assess their compliance with the laws of the United States and professional standards. The PCAOB is currently unable to conduct inspections without the approval of the PRC government authorities. Raytech Holding's U.S. auditor is subject to PCAOB inspections on a regular basis, and we have no operations in mainland China. However, if there is significant change to current political arrangements between mainland China and Hong Kong, companies operated in Hong Kong like us may face similar regulatory risks as those operated in mainland China and we cannot assure you that Raytech Holding's auditor's work will continue to be able to be inspected by the PCAOB. As part of a continued regulatory focus in the United States on access to audit and other information currently protected by national law, in particular mainland China's, in June 2019, a bipartisan group of lawmakers introduced bills in both houses of the U.S. Congress which, if passed, would require the SEC to maintain a list of issuers for which PCAOB is not able to inspect or investigate the audit work performed by a foreign public accounting firm completely. The proposed Ensuring Quality Information and Transparency for Abroad-Based Listings on our Exchanges ("EQUITABLE") Act prescribes increased disclosure requirements for these issuers and, beginning in 2025, the delisting from U.S. national securities exchanges such as the Nasdaq of issuers included on the SEC's list for three consecutive years, thus reducing the time period for triggering the prohibition on trading. It is unclear if this proposed legislation will be enacted. Furthermore, there have been recent deliberations within the U.S. government regarding potentially limiting or restricting China-based companies from accessing U.S. capital markets. On May 20, 2020, the U.S. Senate passed the HFCA Act, which includes requirements for the SEC to identify issuers whose audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely because of a restriction imposed by a non-U.S. authority in the auditor's local jurisdiction. The U.S. House of Representatives passed the HFCA Act on December 2, 2020, and the HFCA Act was signed into law on December 18, 2020. Additionally, in July 2020, the U.S. President's Working Group on Financial Markets issued recommendations for actions that can be taken by the executive branch, the SEC, the PCAOB or other federal agencies and department with respect to Chinese companies listed on U.S. stock exchanges and their audit firms, in an effort to protect investors in the United States. In response, on November 23, 2020, the SEC issued guidance highlighting certain risks (and their implications to U.S. investors) associated with investments in China-based issuers and summarizing enhanced disclosures the SEC recommends China-based issuers make regarding such risks. On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCA Act. Raytech Holding will be required to comply with these rules if the SEC identifies Raytech Holding as having a "non-inspection" year (as defined in the interim final rules) under a process to be subsequently established by the SEC. The SEC is assessing how to implement other requirements of the HFCA Act, including the listing and trading prohibition requirements described above. Under the HFCA Act, Raytech Holding's securities may be prohibited from trading on the Nasdaq or other U.S. stock exchanges if Raytech Holding's auditor is not inspected by the PCAOB for three consecutive years, and this ultimately could result in Raytech Holding's Ordinary Shares being delisted. Furthermore, on June 22, 2021, the U.S. Senate passed the AHFCAA, which would amend the HFCA Act and require the SEC to prohibit an issuer's securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three, thus reducing the time period for triggering the prohibition on trading. On September 22, 2021, the PCAOB adopted a final rule implementing the AHFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the AHFCAA, whether the Board is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. On November 5, 2021, the SEC approved the PCAOB's Rule 6100, Board Determinations Under the Holding Foreign Companies Accountable Act. Rule 6100 provides a framework for the PCAOB to use when determining, as contemplated under the AHFCAA, whether it is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the AHFCAA. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions. On December 16, 2021, the SEC announced that the PCAOB designated mainland China and Hong Kong as the jurisdictions where the PCAOB is not allowed to conduct full and complete audit inspections as mandated under the HFCA Act. On August 26, 2022, a Statement of Protocol was signed by the PCAOB, the CSRC and the Ministry of Finance of the PRC governing inspections and investigations of audit firms based in mainland China and Hong Kong. Pursuant to the Statement of Protocol, the PCAOB conducted inspections on select registered public accounting firms subject to the Determination Report in Hong Kong between September and November 2022. On December 15, 2022, the PCAOB board announced that it has completed the inspections, determined that it had complete access to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, and voted to vacate the Determination Report. On December 29, 2022, the CAA was signed into law by President Biden. The CAA contained, among other things, an identical provision to the AHFCAA, which reduces the number of consecutive non-inspection years required for triggering the prohibitions under the HFCA Act from three years to two. Raytech Holding's auditor is based in the Singapore and therefore is not currently subject to the determinations announced by the PCAOB on December 16, 2021. Notwithstanding the foregoing, in the future, if there is any regulatory change or step taken by PRC regulators that does not permit Assentsure PAC to provide audit work papers located in mainland China or Hong Kong to the PCAOB for inspection or investigation, or the PCAOB re-evaluates its determination as a result of any obstruction with the implementation of the Statement of Protocol in the future, the trading in Raytech Holding's securities may be prohibited under the HFCA Act, ultimately resulting in a determination by a securities exchange to delist our securities. Delisting of Raytech Holding's Ordinary Shares would force holders of Raytech Holding's Ordinary Shares to sell their Ordinary Shares. The market price of Raytech Holding's Ordinary Shares could be adversely affected as a result of the anticipated negative impacts of these executive or legislative actions upon, regardless of whether these executive or legislative actions are implemented and regardless of our actual operating performance. The SEC is assessing how to implement other requirements of the AHFCAA, including the listing and trading prohibition requirements described above. Future developments in respect of increasing U.S. regulatory access to audit information are uncertain, as the legislative developments are subject to the legislative process and the regulatory developments are subject to the rule-making process and other administrative procedures.

  • Share Price & Shareholder Rights - Risk 11
    Raytech Holding's Ordinary Shares are thinly traded and you may be unable to sell at or near ask prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate your shares.

    Raytech Holding's Ordinary Shares may be thinly traded, meaning that the number of persons interested in purchasing Raytech Holding's Ordinary Shares at or near bid prices at any given time may be relatively small or non-existent. This situation may be attributable to a number of factors, including the fact that Raytech Holding is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if Raytech Holding came to the attention of such persons, they tend to be risk-averse and might be reluctant to follow an unproven company such as Raytech Holding or purchase or recommend the purchase of Raytech Holding's shares until such time as Raytech Holding became more seasoned. As a consequence, there may be periods of several days or more when trading activity in Raytech Holding's shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. A broad or active public trading market for Raytech Holding's Ordinary Shares may not develop or be sustained.

  • Share Price & Shareholder Rights - Risk 12
    The market price for our shares may be volatile.

    The trading prices of our Ordinary Shares are likely to be volatile and could fluctuate widely due to factors beyond our control. This may happen because of broad market and industry factors, like the performance and fluctuation in the market prices or the underperformance or deteriorating financial results of internet or other companies based in Hong Kong or China that have listed their securities in the United States in recent years. The securities of some of these companies have experienced significant volatility since their initial public offerings, including, in some cases, a substantial decline in their trading prices. The trading performances of other Hong Kong or Chinese companies' securities after their offerings may affect the attitudes of investors toward Hong Kong or Chinese companies listed in the United States, which consequently may impact the trading performance of our Ordinary Shares, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or other matters of other Hong Kong or Chinese companies may also negatively affect the attitudes of investors towards Hong Kong or Chinese companies in general, including us, regardless of whether we have conducted any inappropriate activities. In addition, securities markets may from time to time experience significant price and volume fluctuations that are not related to our operating performance, which may have a material adverse effect on the market price of our shares. In addition to the above factors, the price and trading volume of our Ordinary Shares may be highly volatile due to multiple factors, including the following: - regulatory developments affecting us, our customers, or our industry;- announcements of studies and reports relating to our service offerings or those of our competitors;- actual or anticipated fluctuations in our quarterly results of operations and changes or revisions of our expected results;- changes in financial estimates by securities research analysts;- announcements by us or our competitors of new product and service offerings, acquisitions, strategic relationships, joint ventures or capital commitments;- additions to or departures of our senior management;- detrimental negative publicity about us, our management or our industry;- fluctuations of exchange rates between the Hong Kong dollar and the U.S. dollar;- release or expiry of lock-up or other transfer restrictions on our outstanding Ordinary Shares; and - sales or perceived potential sales of additional Ordinary Shares.

  • Share Price & Shareholder Rights - Risk 13
    Substantial future sales of Raytech Holding's Ordinary Shares or the anticipation of future sales of Raytech Holding's Ordinary Shares in the public market could cause the price of Raytech Holding's Ordinary Shares to decline.

    Sales of substantial amounts of Raytech Holding's Ordinary Shares in the public market or the perception that these sales could occur, could cause the market price of Raytech Holding's Ordinary Shares to decline. Sales of these shares into the market could cause the market price of Raytech Holding's Ordinary Shares to decline.

  • Share Price & Shareholder Rights - Risk 14
    If securities or industry analysts do not publish research or reports about Raytech Holding's business, or if they publish a negative report regarding Raytech Holding's Ordinary Shares, the price of Raytech Holding's Ordinary Shares and trading volume could decline.

    The trading market for Raytech Holding's Ordinary Shares may depend in part on the research and reports that industry or securities analysts publish about Raytech Holding or its business. We do not have any control over these analysts. If one or more of the analysts who cover Raytech Holding downgrade Raytech Holding, the price of Raytech Holding's Ordinary Shares would likely decline. If one or more of these analysts cease coverage of Raytech Holding or fail to regularly publish reports on Raytech Holding, Raytech Holding could lose visibility in the financial markets, which could cause the price of Raytech Holding's Ordinary Shares and the trading volume to decline.

  • Share Price & Shareholder Rights - Risk 15
    Raytech Holding may experience extreme stock price volatility unrelated to its actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of Raytech Holding's Ordinary Shares, and such volatility may subject Raytech Holding to securities litigation.

    The market for Raytech Holding's Ordinary Shares may have, when compared to seasoned issuers, significant price volatility and we expect that Raytech Holding's share price may continue to be more volatile than that of a seasoned issuer for the indefinite future. Recently, there have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with a number of recent initial public offerings, especially among companies with relatively smaller public floats. As a relatively small-capitalization company with relatively small public float, Raytech Holding may experience greater stock price volatility, extreme price run-ups, lower trading volume and less liquidity than large-capitalization companies. In particular, Raytech Holding's Ordinary Shares may be subject to rapid and substantial price volatility, low volumes of trades and large spreads in bid and ask prices. Such volatility, including any stock-run up, may be unrelated to Raytech Holding's actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of Raytech Holding's Ordinary Shares. In addition, if the trading volumes of Raytech Holding's Ordinary Shares are low, persons buying or selling in relatively small quantities may easily influence prices of our Ordinary Shares. This low volume of trades could also cause the price of Raytech Holding's Ordinary Shares to fluctuate greatly, with large percentage changes in price occurring in any trading day session. Holders of Raytech Holding's Ordinary Shares may also not be able to readily liquidate their investment or may be forced to sell at depressed prices due to low volume trading. Broad market fluctuations and general economic and political conditions may also adversely affect the market price of Raytech Holding's Ordinary Shares. As a result of this volatility, investors may experience losses on their investment in Raytech Holding's Ordinary Shares. A decline in the market price of Raytech Holding's Ordinary Shares also could adversely affect its ability to issue additional shares of Ordinary Shares or other securities and Raytech Holding's ability to obtain additional financing in the future. No assurance can be given that an active market in Raytech Holding's Ordinary Shares will develop or be sustained. If an active market does not develop, holders of Raytech Holding's Ordinary Shares may be unable to readily sell the shares they hold or may not be able to sell their shares at all. In the past, plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. Raytech Holding may, in the future, be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and could divert management's attention and resources.

  • Share Price & Shareholder Rights - Risk 16
    You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because Raytech Holding is incorporated under British Virgin Islands law.

    Raytech Holding is a company incorporated under the laws of the British Virgin Islands. Raytech Holding's corporate affairs are governed by its memorandum and articles of association, the BVI Act and the common law of the British Virgin Islands. The rights of shareholders to take action against Raytech Holding's directors, actions by its minority shareholders and the fiduciary duties of Raytech Holding's directors to it under the British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands. The common law of the British Virgin Islands is derived in part from comparatively limited judicial precedent in the British Virgin Islands as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not binding, on a court in the British Virgin Islands. The rights of Raytech Holding's shareholders and the fiduciary duties of its directors under the British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the British Virgin Islands has a less developed body of securities laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the British Virgin Islands. In addition, British Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. Certain corporate governance practices in the British Virgin Islands, where Raytech Holding was incorporated, differ significantly from requirements for companies incorporated in other jurisdictions such as the United States. Raytech Holding is permitted to rely on home country practice with respect to its corporate governance. Raytech Holding has relied on home country practice with respect to certain corporate governance matters, including its reliance on the home country practice exemption in Nasdaq Listing Rule 5615(a)(3) in lieu of the shareholder approval requirements of Nasdaq Listing Rule 5635 in connection with its June 2026 registered direct offering, and may continue to rely on home country practice in the future. If Raytech Holding chooses to follow the British Virgin Islands' practice in the future, its shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S. domestic issuers. See "Risk Factors – Risks Related to Our Ordinary Shares – As a foreign private issuer, Raytech Holding is permitted to, and Raytech Holding will, rely on exemptions from certain Nasdaq Stock Exchange corporate governance standards applicable to domestic U.S. issuers. This may afford less protection to holders of Raytech Holding's shares." on page 32 of this Annual Report. As a result of all of the above, public shareholders may have more difficulties in protecting their interests in the face of actions taken by Raytech Holding's management, or members of its board of directors, than they would as public shareholders of a company incorporated in the United States.

  • Share Price & Shareholder Rights - Risk 17
    As a foreign private issuer, Raytech Holding is permitted to, and it will, rely on exemptions from certain Nasdaq Stock Exchange corporate governance standards applicable to domestic U.S. issuers. This may afford less protection for holders of our shares.

    Raytech Holding is exempted from certain corporate governance requirements of the Nasdaq listing rules by virtue of being a foreign private issuer. Raytech Holding is required to provide a brief description of the significant differences between our corporate governance practices and the corporate governance practices required to be followed by domestic U.S. companies listed on the Nasdaq. The standards applicable to Raytech Holding are considerably different than the standards applied to domestic U.S. issuers. For instance, Raytech Holding is not required to: - have a majority of the board be consisted of independent directors (although all of the members of the audit committee must be independent under the Exchange Act);- have a compensation committee or a nominating or corporate governance committee consisting entirely of independent directors;         - have regularly scheduled executive sessions with only independent directors; or         - have executive sessions of solely independent directors each year. Raytech Holding has relied on and intends to continue to rely on some of these exemptions. As a result, you may not be provided with the benefits of certain corporate governance requirements of Nasdaq.

  • Share Price & Shareholder Rights - Risk 18
    If Raytech Holding cannot continue to satisfy the continuous listing requirements and other rules of the Nasdaq Capital Market, although Raytech Holding is exempt from certain corporate governance standards applicable to US issuers as a Foreign Private Issuer, our securities may be delisted, which could negatively impact the price of Raytech Holding's securities and your ability to sell them.

    Even though Raytech Holding's securities are listed on the Nasdaq Capital Market, we cannot assure you that Raytech Holding's securities will continue to be listed on the Nasdaq Capital Market. In order to maintain Raytech Holding's listing on the Nasdaq Capital Market, Raytech Holding will be required to comply with certain rules of the Nasdaq Capital Market, including those regarding minimum shareholders' equity, minimum share price and certain corporate governance requirements. Although Raytech Holding has initially met the listing requirements and other applicable rules of the Nasdaq Capital Market, it may not be able to continue to satisfy these requirements and applicable rules. If Raytech Holding is unable to satisfy the Nasdaq Capital Market criteria for maintaining our listing, its securities could be subject to delisting. If the Nasdaq Capital Market delists Raytech Holding's securities from trading, Raytech Holding could face significant consequences, including: - a limited availability for market quotations for Raytech Holding's securities;         - reduced liquidity with respect to Raytech Holding's securities;         - a determination that Raytech Holding's Ordinary Shares are a "penny stock," which will require brokers trading in Raytech Holding's Ordinary Share to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for Raytech Holding's Ordinary Shares;         - limited amount of news and analyst coverage; and         - a decreased ability to issue additional securities or obtain additional financing in the future.

  • Share Price & Shareholder Rights - Risk 19
    It may be difficult for overseas shareholders and/or regulators to conduct investigations or collect evidence within mainland China.

    Shareholder claims or regulatory investigations that are common in the United States generally are difficult to pursue as a matter of law or practicality in mainland China. For example, in mainland China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation initiated outside mainland China. Although the authorities in mainland China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation with the securities regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanisms. Furthermore, according to Article 177 of the PRC Securities Law of mainland China of the PRC, or Article 177, which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the mainland China. While detailed interpretation of or implementation rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator to directly conduct investigation or evidence collection activities within mainland China may further increase difficulties faced by you in protecting your interests. Our principal business operation is conducted in Hong Kong. In the event that the U.S. regulators carry out investigation on Raytech Holding and there is a need to conduct investigation or collect evidence within the territory of the mainland China, the U.S. regulators may not be able to carry out such investigation or evidence collection directly in mainland China under the laws and regulations of mainland China. The U.S. regulators may consider cross-border cooperation with securities regulatory authority of mainland China by way of judicial assistance, diplomatic channels or regulatory cooperation mechanism established with the securities regulatory authority of mainland China.

See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

FAQ

What are “Risk Factors”?
Risk factors are any situations or occurrences that could make investing in a company risky. The Securities and Exchange Commission (SEC) requires that publicly traded companies disclose their most significant risk factors. This is so that potential investors can consider any risks before they make an investment. They also offer companies protection, as a company can use risk factors as liability protection. This could happen if a company underperforms and investors take legal action as a result. It is worth noting that smaller companies, that is those with a public float of under $75 million on the last business day, do not have to include risk factors in their 10-K and 10-Q forms, although some may choose to do so.
How do companies disclose their risk factors?
Publicly traded companies initially disclose their risk factors to the SEC through their S-1 filings as part of the IPO process. Additionally, companies must provide a complete list of risk factors in their Annual Reports (Form 10-K) or (Form 20-F) for “foreign private issuers”. Quarterly Reports also include a section on risk factors (Form 10-Q) where companies are only required to update any changes since the previous report. According to the SEC, risk factors should be reported concisely, logically and in “plain English” so investors can understand them.
How can I use TipRanks risk factors in my stock research?
Use the Risk Factors tab to get data about the risk factors of any company in which you are considering investing. You can easily see the most significant risks a company is facing. Additionally, you can find out which risk factors a company has added, removed or adjusted since its previous disclosure. You can also see how a company’s risk factors compare to others in its sector. Without reading company reports or participating in conference calls, you would most likely not have access to this sort of information, which is usually not included in press releases or other public announcements. A simplified analysis of risk factors is unique to TipRanks.
What are all the risk factor categories?
TipRanks has identified 6 major categories of risk factors and a number of subcategories for each. You can see how these categories are broken down in the list below. 1. Financial & Corporate Accounting & Financial Operations - risks related to accounting loss, value of intangible assets, financial statements, value of intangible assets, financial reporting, estimates, guidance, company profitability, dividends, fluctuating results. Share Price & Shareholder Rights – risks related to things that impact share prices and the rights of shareholders, including analyst ratings, major shareholder activity, trade volatility, liquidity of shares, anti-takeover provisions, international listing, dual listing. Debt & Financing – risks related to debt, funding, financing and interest rates, financial investments. Corporate Activity and Growth – risks related to restructuring, M&As, joint ventures, execution of corporate strategy, strategic alliances. 2. Legal & Regulatory Litigation and Legal Liabilities – risks related to litigation/ lawsuits against the company. Regulation – risks related to compliance, GDPR, and new legislation. Environmental / Social – risks related to environmental regulation and to data privacy. Taxation & Government Incentives – risks related to taxation and changes in government incentives. 3. Production Costs – risks related to costs of production including commodity prices, future contracts, inventory. Supply Chain – risks related to the company’s suppliers. Manufacturing – risks related to the company’s manufacturing process including product quality and product recalls. Human Capital – risks related to recruitment, training and retention of key employees, employee relationships & unions labor disputes, pension, and post retirement benefits, medical, health and welfare benefits, employee misconduct, employee litigation. 4. Technology & Innovation Innovation / R&D – risks related to innovation and new product development. Technology – risks related to the company’s reliance on technology. Cyber Security – risks related to securing the company’s digital assets and from cyber attacks. Trade Secrets & Patents – risks related to the company’s ability to protect its intellectual property and to infringement claims against the company as well as piracy and unlicensed copying. 5. Ability to Sell Demand – risks related to the demand of the company’s goods and services including seasonality, reliance on key customers. Competition – risks related to the company’s competition including substitutes. Sales & Marketing – risks related to sales, marketing, and distribution channels, pricing, and market penetration. Brand & Reputation – risks related to the company’s brand and reputation. 6. Macro & Political Economy & Political Environment – risks related to changes in economic and political conditions. Natural and Human Disruptions – risks related to catastrophes, floods, storms, terror, earthquakes, coronavirus pandemic/COVID-19. International Operations – risks related to the global nature of the company. Capital Markets – risks related to exchange rates and trade, cryptocurrency.